Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intra-orally Twice Daily in Patients With Oral Lichen Planus (OLP) Using Rivelin®-CLO Patches
Conditions
Interventions
Clobetasol Propionate
Locations
27
United States
QWay Research
Hialeah, Florida, United States
Vitae Research Center, LLC
Miami, Florida, United States
Valencia Medical & Research Center
Miami, Florida, United States
The Dental College of Georgia
Augusta, Georgia, United States
Tufts University, School of Dental Medicine
Boston, Massachusetts, United States
Brigham and Women's Hospital, Division of Oral Medicine and Dentistry
Boston, Massachusetts, United States
Start Date
June 28, 2018
Primary Completion Date
December 20, 2019
Completion Date
December 20, 2019
Last Updated
July 14, 2020
NCT06932848
NCT07131813
NCT06321003
NCT06810752
NCT06697574
NCT05401201
Lead Sponsor
Dermtreat
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions